Camp4 Therapeutics Corporation · NASDAQ:CAMP

Trails Edge Capital Partners, LP reported a 6.00% stake in Camp4 Therapeutics Corporation (Schedule 13G)

Event Aug 3, 2026 · Filed Aug 10, 2026

Trails Edge Capital Partners, LP reported a 6.00% stake in Camp4 Therapeutics Corporation, 3,790,636 shares, as a passive investor on Aug 3, 2026. Filed Aug 10, 2026 (Schedule 13G).

Stake
6.00%
Shares
3,790,636
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Trails Edge Capital Partners, LP6.00%3,790,636
Trails Edge Biotechnology Master Fund, LP6.00%3,790,636
Ortav Yehudai6.00%3,790,636

Source

View original at SEC

Related